The company has witnessed 150 per cent growth in the number of products sold as compared to 2014, it said in a statement.
*******
Novartis launches Sequadra inhaler for COPD patients * Novartis Healthcare today announced the launch of Sequadra inhaler for Chronic Obstructive Pulmonary Disease (COPD) patients.
The company has launched Sequadra iInhaler (indacaterol/ glycopyrronium), a fixed dose combination (FDC) of two bronchodilating active ingredients, indacaterol maleate, a long-acting beta2-adrenergic agonist (LABA) and glycopyrronium bromide, a long-acting anticholinergic (LAMA), for treatment of COPD, it said in a statement.
Softbank India entrusts exec search mandate to Hunt Partners * Executive search firm Hunt Partners has received a formal mandate for senior executive talent search from Softbank India.
"The Softbank mandate is a shot in the arm for us as it involves identifying and on-boarding the right leadership talent in Indian market for one of the world's most high profile holding firms," Hunt Partners Managing Partner Sumit Mehra said.